International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 2 , Pages 391-395, 1 February 2008

Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity

  • Howard Safran, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • Corresponding Author InformationReprint requests to: Howard Safran, M.D., Department of Medicine, The Miriam Hospital, 164 Summit Ave., Providence, RI 02906. Tel: (401) 793-7151; Fax: (401) 793-4049
    • ,
  • Mohan Suntharalingam, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD
    • ,
  • Thomas Dipetrillo, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Thomas Ng, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • L. Austin Doyle, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • University of Maryland Cancer Center, Baltimore, MD
    • ,
  • Mark Krasna, M.D.

      Affiliations

    • Department of Surgery, University of Maryland School of Medicine, Baltimore, MD
    • ,
  • Angela Plette, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Devon Evans, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Harold Wanebo, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Paul Akerman, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Jeremy Spector, M.D.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Nancy Kennedy, R.N., C.C.R.A.

      Affiliations

    • Brown University Oncology Group, Providence, RI
    • ,
  • Teresa Kennedy, R.N., C.C.R.A.

      Affiliations

    • Brown University Oncology Group, Providence, RI

Received 25 May 2007; received in revised form 3 July 2007; accepted 4 July 2007. published online 01 November 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented in part at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), November 5–9, 2006, Philadelphia, PA.

 Dr. Safran and Dr. Mohan report receiving grant support and honoraria from Bristol-Myers in the amount of less than $100,000. No other potential conflict of interest relevant to this article was reported.

PII: S0360-3016(07)03668-1

doi:10.1016/j.ijrobp.2007.07.2325

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 2 , Pages 391-395, 1 February 2008

Article Tools